21st Continuing Professional Development (CPD) Series: Diabetes Asia 2024 Conference
In-Person Event
Oct 17 - 19, 2024
Kuala Lumpur, Kuala Lumpur, MYOVERVIEW
21st Continuing Professional Development (CPD) Series: Diabetes Asia 2024 Conference is organized by National Diabetes Institute (NADI) and will be held from Oct 17 - 19, 2024 at Royale Chulan Kuala Lumpur, Kuala Lumpur, Kuala Lumpur, Malaysia.
Objectives of the Conference:
The Continuing Professional Development (CPD) Series as Diabetes Asia 2024 Conference aims to help improve management of diabetes with emphasis on recent advances and practical aspects of diabetes care. Participants are expected to be able to:
• Appreciate recent advances and practical aspects of diabetes care
• Understand ways of ensuring early diagnosis andoptimal management for good control of diabetes, its complications and associated diseases
• Apply knowledge gained during the Conference to further improve care for persons with diabetes in the community
KEY DATES
ACTIVITY SCHEDULE
October 17, 2024 | 1 SessionIn personDiabetes topic related
Scientific Programme*
International speakers will be delivering lectures IN-PERSON on subjects of current interest relevant to diabetes care during Plenary and Symposium Sessions. They may also be the resource persons for Meet-the Professor Sessions
Local experts will participate in-person in symposiums and case discussion sessions
Plenary Topics:
1. Managing Diabetes with Gut Hormone Receptor Agonists
2. Diabetes in Asia - From Epidemiology to Precision Medicine
3. New Developments in the Field of T1DM - Is It Curable In the Near Future?
4. Challenges in Diabetes Care in Developing Countries
5. Effective and Safe Strategies in the Management of Diabetes In Older Persons
6. Current Approach in Managing People with Obesity and T2DM
Symposium Themes/Topics Include:
Main Symposium 1A
Theme: Treating Diabetes Beyond Glucose: New Drugs
Topics: 1. Dual Incretin and Triple G Agonists
2. Small Molecule, Oral GLP-1 Agonists
3. Managing Off-target Effects of GLP-1 Agonists
Main Symposium 2A
Theme: Advances in The Management of Diabetic Macrovascular Complications
Topics: 1. Treatment for Cardiovascular Residual Risk in Diabetes
2. Heart Failure in Diabetics: Early Diagnosis and Treatment
3. Peripheral Artery Disease in Diabetics: How Best to Diagnose and Treat
Main Symposium 3A
Theme: New Knowledge in the Prevention and Treatment of Microvascular Complications
Topics: 1. Managing Beyond Antihyperglycemic and Antihypertensive Agents for Diabetic Kidney Disease
2. Emerging Treatment Strategies for Diabetic Retinopathy
3. Advances in the Management of Diabetic Foot Ulcer
Main Symposium 4A
Theme: Diabetes in Children & Adolescents
Topics: 1. Challenges in Managing Diabetes in Children with Obesity
2. Children & Adolescents with Diabetes Complications: Can we predict and prevent?
3. CGMS and Insulin Pumps in Children: what outcome measures should we be looking for?
Main Symposium 5A
Theme: Managing Diabetes in Special Groups
Topics: 1. Hyperlipidaemia in High-risk Diabetics Not Responding Adequately to Statin: What’s Next?
2. Depression in Diabetics: Early Recognition and Management
3. Diabetes in Pregnancy: Oral or Injectable; Finger Pricks or CGM?
* Subject to change
TARGET AUDIENCE
PhysicianPharmacistSurgeonsResearchersNutritionistsDietitianGeneral PractitionerMedical AssistantsSurgical specialistsLicensed Vocational Nurses (LVN)Primary Care PhysiciansDietitianTraineesSenior and Junior DoctorsClinical NutritionSPECIALITIES
Endocrinology, Metabolism and DiabetesDiabetes NurseSUGGESTED HOTELS
CONFERENCE VENUE
Royale Chulan Kuala LumpurCANCELLATION & REFUND POLICY
Cancellation & Transfer
- If you are unable to participate, a replacement is allowed at no extra cost provided written notice is given prior to the event.
- A 90% refund can be made for cancellation received in writing or by fax at least 4 weeks before the event.
- A 50% refund will be given if cancellation is received 14 days before the event.
